I’m in Munich and people keep asking me to decode Vance’s speech. OK: In Vance English “free speech” means “Let Musk run your elections” and “democracy” means “let Russia run your elections.” Now move on. 2025 is about what Europeans do, not what Americans say.
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺 V 🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺 O 🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺 T 🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺 E 🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🗳️🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺🇪🇺
#UseYourVote
Join us at our new department "Metabolism, Senescence and Autophagy" at the Research Center One Health & University Clinic Essen https://t.co/pFEBsxnwuX
Registration is open NOW for our joint symposium on lysosomes and autophagy by the DFG research unit FOR2625 and the ESGLD in Berlin, Germany in June. Don't wait too long as the number of participants is limited... Please share and re-tweet! See you in Berlin 🥳 #lysosomes
🌐 Discover how Antisense oligonucleotide-driven mTORC2 inhibition may be a game-changer in experimental and genetic mouse models of epilepsy.
Special thanks to Mauro Costa-Mattioli and team for this nice collaboration! 👏
https://t.co/sQ27LvhHd7
#ASO#mTOR#epilepsy#FCD
Der 3. Deutsche Krebsforschungskongress hat begonnen. Von neu entdeckten Mechanismen der Krebsentstehung bis hin zu innovativen Ansätzen der Präzisionsmedizin: Das ist das thematische Spektrum, zu dem sich Experten aus der #Krebsforschung bis Mittwoch austauschen. #dkfk#gcrc2023
Thrilled to share Michael's new story published in Cell: We identify a nutrient-regulated phosphoinositide switch that triggers the conversion between motile mTORC1 signaling-active anabolic and static mTORC1 signaling-inactive degradative lysosomes. https://t.co/S5EKRbxweK
Enjoyed so much the 'TOR de France' meting last week! Many thanks to the organisers @MarioPende, @BaulacS, @DokudovskayaS, and all amazing speakers and participants for making it so special!
Always a great opportunity to meet good friends and colleagues!
@MesiStrat is studying #breastcancer metabolism to develop easily measurable marker panels to help clinical decision-making throughout endocrine therapy.
This method will increase cost effectiveness of the treatment and the patients’ quality of life.
It’s International Day of Action for Women's Health!
Let’s take a closer look at 3 #H2020 projects that are promoting and safeguarding women’s health in Europe.
#WomensHealthMatters
Excited to share our latest review with @cmuyehara@CellReports discussing advances in the ever-changing field of enhancer-promoter interactions with an emphasis on the roles and functions of complex 3D hubs https://t.co/DAvf7g1MIg